These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 26535553)

  • 1. Correction to: J Ocul Pharmacol Ther 2015;31(7);413-418; DOI: 10.1089/jop.2015.0017.
    J Ocul Pharmacol Ther; 2015 Nov; 31(9):585. PubMed ID: 26535553
    [No Abstract]   [Full Text] [Related]  

  • 2. Correction to:
    J Ocul Pharmacol Ther; 2020; 36(1):70-71. PubMed ID: 31971894
    [No Abstract]   [Full Text] [Related]  

  • 3. Correction to: Matrix Metalloproteinases and Glaucoma Treatment, by Weinreb, R.N., Robinson, M.R., Dibas, M. and Stamer, W.D. J Ocul Pharmacol Ther 2020;36(4):208-228. DOI: 10.1089/jop.2019.0146.
    J Ocul Pharmacol Ther; 2020; 36(6):484. PubMed ID: 32721205
    [No Abstract]   [Full Text] [Related]  

  • 4. Correction to:
    J Ocul Pharmacol Ther; 2019 Dec; 35(10):578. PubMed ID: 31794284
    [No Abstract]   [Full Text] [Related]  

  • 5. Correction to: Efficacy and Safety of 0.6% Pazufloxacin Ophthalmic Solution Versus Moxifloxacin 0.5% and Gatifloxacin 0.3% in Subjects with Bacterial Conjunctivitis: A Randomized Clinical Trial, by Baiza-Durán, L., Olvera-Montaño, O., Mercado-Sesma, A.R., and Oregon-Miranda, A.A. J Ocul Pharmacol Ther 2018;34(3):250-255. DOI: 10.1089/jop.2017.0056.
    J Ocul Pharmacol Ther; 2019; 35(1):76. PubMed ID: 30699060
    [No Abstract]   [Full Text] [Related]  

  • 6.
    J Ocul Pharmacol Ther; 2023 Jun; 39(5):359. PubMed ID: 37310367
    [No Abstract]   [Full Text] [Related]  

  • 7. Correction to:
    J Ocul Pharmacol Ther; 2019 Nov; 35(9):522. PubMed ID: 31682183
    [No Abstract]   [Full Text] [Related]  

  • 8. Correction to: The Effect of Posture on Intraocular Pressure and Systemic Hemodynamic Parameters in Treated and Untreated Patients with Primary Open-Angle Glaucoma, by Katsanos, A., Dastiridou, A.I., Quaranta, L., Rulli, E., Riva, I., Dimasi, V., Tsironi, E.E., and Weinreb, R.N. J Ocul Pharmacol Ther 2017;33(8):598-603. DOI: 10.1089/jop.2017.0030.
    J Ocul Pharmacol Ther; 2018 Apr; 34(3):309. PubMed ID: 29393727
    [No Abstract]   [Full Text] [Related]  

  • 9. Correction to:
    J Ocul Pharmacol Ther; 2020 Mar; 36(2):133. PubMed ID: 32150501
    [No Abstract]   [Full Text] [Related]  

  • 10. Ocular gelfoam disc-applicator for pupillary dilation in humans. Negvesky GJ, butrus SI, abifarah HA, lee YC, yalkowsky SH(1). J ocul pharmacol ther 2000;16:311-315.
    Am J Ophthalmol; 2000 Dec; 130(6):864. PubMed ID: 11124328
    [No Abstract]   [Full Text] [Related]  

  • 11. Re: "Pharmacokinetic Analysis of Intraocular Penetration of Latanoprost Solutions with Different Preservatives in Human Eyes" by Sekine et al. (J. Ocul. Pharmacol. Ther. 2018;34:280-286).
    Novack GD
    J Ocul Pharmacol Ther; 2018; 34(6):429-430. PubMed ID: 29924675
    [No Abstract]   [Full Text] [Related]  

  • 12. Letter to the editor regarding Gerente, V.M., Biondi, A.C., Barbosa, C.P., et al. Effect of brimonidine tartrate 0.15% on scotopic pupil: controlled trial. J. Ocul. Pharmacol. Ther 23:476-480, 2007.
    Khanani AM; Brown SM
    J Ocul Pharmacol Ther; 2008 Jun; 24(3):364-5; author reply 366. PubMed ID: 18476806
    [No Abstract]   [Full Text] [Related]  

  • 13. Notice of Retraction: Harada S, Yamazaki Y, and Tokuyama S (2013) Orexin-A Suppresses Postischemic Glucose Intolerance and Neuronal Damage through Hypothalamic Brain-Derived Neurotrophic Factor,
    J Pharmacol Exp Ther; 2020 Nov; 375(2):397. PubMed ID: 33115940
    [No Abstract]   [Full Text] [Related]  

  • 14. Re: Norman AB, Tabet MR, Norman MK, and Tsibulsky VL (2014) Maintained Cocaine Self-Administration Is Determined by Quantal Responses: Implications for the Measurement of Antagonist Potency. J Pharmacol Exp Ther 348:311-315; doi:10.1124/jpet.113.210690.
    J Pharmacol Exp Ther; 2016 Aug; 358(2):241. PubMed ID: 27370348
    [No Abstract]   [Full Text] [Related]  

  • 15. Notice of Concern: Kawas LH, McCoy AT, Yamamoto BJ, Wright JW, and Harding JW (2012) Development of Angiotensin IV Analogs as Hepatocyte Growth Factor/Met Modifiers,
    J Pharmacol Exp Ther; 2021 Sep; 378(3):314. PubMed ID: 34551990
    [No Abstract]   [Full Text] [Related]  

  • 16. Notice of Concern: Kawas LH, Yamamoto BJ, Wright JW, and Harding JW (2011) Mimics of the Dimerization Domain of Hepatocyte Growth Factor Exhibit Anti-Met and Anticancer Activity,
    J Pharmacol Exp Ther; 2021 Sep; 378(3):312. PubMed ID: 34551988
    [No Abstract]   [Full Text] [Related]  

  • 17. Corrigendum to "Presence and function of β-adrenergic receptors in primary equine bronchial epithelia cells" [Pulm Pharmacol Ther. (2020 Apr) 61 101897] DOI: 10.1016/j.pupt.2020.101897.
    Schellenberg LM; Bonicelli J; Hochheim I; Regenthal R; Abraham G
    Pulm Pharmacol Ther; 2021 Dec; 71():102093. PubMed ID: 34801872
    [No Abstract]   [Full Text] [Related]  

  • 18. Notice of Concern: McCoy AT, Benoist CC, Wright JW, Kawas LH, Bule-Ghogare JM, Zhu M, Appleyard SM, Wayman GA, and Harding JW (2013) Evaluation of Metabolically Stabilized Angiotensin IV Analogs as Procognitive/Antidementia Agents,
    J Pharmacol Exp Ther; 2021 Sep; 378(3):313. PubMed ID: 34551989
    [No Abstract]   [Full Text] [Related]  

  • 19. Notice of Concern: Benoist CC, Kawas LH, Zhu M, Tyson KA, Stillmaker L, Appleyard SM, Wright JW, Wayman GA, and Harding JW (2014) The Procognitive and Synaptogenic Effects of Angiotensin IV-Derived Peptides Are Dependent on Activation of the Hepatocyte Growth Factor/c-Met System,
    J Pharmacol Exp Ther; 2021 Sep; 378(3):311. PubMed ID: 34551987
    [No Abstract]   [Full Text] [Related]  

  • 20. Re: Furutani T, Takeyama K-i., Tanabe M, Koutoku H, Ito S, Taniguchi N, Suzuki E, Kudoh M, Shibasaki M, Shikama H, and Kato S (2005) Human expanded polyglutamine androgen receptor mutants in neurodegeneration as a novel ligand target. J Pharmacol Exp Ther 315:545-552; doi:10.1124/jpet.105.087643.
    J Pharmacol Exp Ther; 2014 Mar; 348(3):493. PubMed ID: 24534945
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.